Adipo Therapeutics presents positive study results about potential obesity treatment
Findings provide encouraging evidence to advance ADPO-002NP treatment toward first-in-human Phase I clinical trials Meng Deng, an associate professor in Purdue University’s colleges of Agriculture and Engineering, is founder of Adipo Therapeutics LLC. The biopharmaceutical company presented data about its active ingredient and lead product at the annual meeting of The Obesity Society. (The ESC […]
